Center for Scientific Review; Notice of Closed Meetings
Published Date: 11/25/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 16-17, 2025, to review grant applications related to musculoskeletal rehabilitation. These meetings protect private info and trade secrets, so the public can’t attend. Researchers applying for grants in this field should note the timing, but no new costs or changes to funding are announced.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
NIH grant review meeting scheduled
The NIH Center for Scientific Review will hold a closed virtual meeting on December 16–17, 2025, from 9:00 a.m. to 7:00 p.m. to review grant applications for musculoskeletal rehabilitation. The meeting is closed to the public to protect confidential trade secrets and personal information, yet the notice also states registration is not required to attend; no new costs or funding changes are announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Previous / Next Documents
Previous: 2025-20944 — Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extension: Rule 6c-11
The SEC is asking to keep collecting info under Rule 6c-11, which helps ETFs run smoothly without extra approvals. This rule affects ETF managers who must update website info, keep records, and follow clear policies, costing about 74,580 hours and nearly $2 million yearly. The extension keeps things transparent and fair, with no new fees or deadlines, just a continuation of current rules.
Next: 2025-20947 — Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just added new people and a ship to its blacklist, meaning their money and property in the U.S. are frozen. Americans can’t do business with them anymore, starting November 12, 2025. This move aims to stop bad actors from using U.S. resources and sends a clear message about who’s off-limits in the financial world.